Hsp90 and its co-chaperone, Sgt1, as autoantigens in dilated cardiomyopathy

被引:0
作者
Lyudmila L. Kapustian
Olga A. Vigontina
Olga T. Rozhko
Dmytro V. Ryabenko
Wojciech Michowski
Wiesława Lesniak
Anna Filipek
Irina V. Kroupskaya
Lyudmila L. Sidorik
机构
[1] Institute of Molecular Biology and Genetics NAS of Ukraine,
[2] Strazhesko Institute of Cardiology MAS of Ukraine,undefined
[3] Nencki Institute of Experimental Biology,undefined
[4] International Institute of Molecular Biology,undefined
来源
Heart and Vessels | 2013年 / 28卷
关键词
Hsp90; Sgt1; Heat shock proteins; Autoantigens; Dilated cardiomyopathy;
D O I
暂无
中图分类号
学科分类号
摘要
Recently, it has been suggested that some heat shock proteins such as Hsp70 and Hsp60 are involved in autoimmune diseases including cardiospecific ones. In this work we focused on the involvement of another well known heat shock protein, Hsp90, and its novel co-chaperone, Sgt1, in dilated cardiomyopathy (DCM). We found that the level of autoantibodies against these two proteins was significantly higher in patients with DCM and ischemic heart disease than in sera of healthy donors. We have also analyzed the expression level and subcellular localization of Hsp90 and Sgt1 in diseased myocardia. Using Western blot we found changes in subcellular localization of Hsp90 in the left ventricle of DCM hearts while the total level of this protein remained unchanged. Regarding the Sgt1 protein, we found an increased level in DCM and no changes in subcellular localization. Taken together, our data suggest that Hsp90 and Sgt1 might be involved in the progression of heart failure and might serve as markers for cardiomyopathies of different origin.
引用
收藏
页码:114 / 119
页数:5
相关论文
共 167 条
[1]  
Maron BJ(2006)Contemporary definitions and classification of the cardiomyopathies. An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation 113 1807-1816
[2]  
Towbin JA(2002)Losing heart: the role of apoptosis in heart diseases—a novel therapeutic target? FASEB J 16 135-146
[3]  
Thiene G(2006)Mechanisms of disease: apoptosis in heart failure—seeing hope in death Nat Clin Pract 3 681-688
[4]  
Antzelevitch C(1991)Natural autoantibodies: from “horror autotoxicus” to “gnothi seauton” Immunol Today 12 154-159
[5]  
Corrado D(2011)Agonist-like autoantibodies against calcium channel in patients with dilated cardiomyopathy Heart Vessels 115 2809-2816
[6]  
Arnett D(2002)Chaperoning signaling pathways: molecular chaperons as stress-sensing “heat shock” proteins J Cell Sci 132 255-258
[7]  
Moss AJ(1996)Roles of molecular chaperones in protein degradation J Cell Biol 4 29-35
[8]  
Seidman CE(1999)Identification of human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies in the peripheral circulation of normal individuals Cell Stress Chaperones 9 51-58
[9]  
Young JB(2005)Hsp60, Bax, apoptosis and the heart J Cell Mol Med 11 1-12
[10]  
Gill C(2006)Antibodies against heat shock proteins in environmental stresses and diseases: friend or foe? Cell Stress Chaperones 51 637-646